首页 > 最新文献

Almanac of Clinical Medicine最新文献

英文 中文
Time-dependent transformations of the internal image of disorder in patients with chronic back pain 慢性背痛患者内部图像紊乱的时间依赖性转换
Pub Date : 2022-12-08 DOI: 10.18786/2072-0505-2022-50-046
A. V. Kotelnikova, A. Kukshina, Anastasia S. Tikhonova, Anna V. Khaustova
Rationale: Pain is the most prevalent symptom of any disease, with back pain comprising 12 to 33%. Chronic back pain ranges fourth among the causes of disability. About 60% of patients with chronic pain have symptoms of depression. However, there is paucity of empirical data on psychological aspects of the pain syndrome chronization in patients with back pain. Aim: To study the temporary transformation of the internal image of disorder in patients with chronic back pain. Materials and methods: In this observational cohort analytical study, we evaluated the contribution of pain duration into the formation of the internal image of disorder in 84 patients with chronic pain lasting for up to 55 years and caused by dorsopathy. The patients (53 women and 31 men aged 23 to 86 years, with pain intensity of up to moderate degree) were those admitted to an in-patient department for the secondary medical rehabilitation. The internal image of disorder was operationalized with the following psychometric scales: McGill Pain Questionnaire, the Restoration of the Locus of Control Scale, the Tampa Scale of Kinesiophobia, and the Psychological Factors of Attitudes to the Disease and its Treatment Scale. Results: The sensory level of the internal image of disorder was characterized by mixed (neuropathic and dysfunctional) pain in 29 (34.5%) of the cases and nociceptive pain in 55 (65.5%) of the cases. In the patients with nociceptive pain, the duration of pain was negatively correlated with their perception of self-efficacy towards the disease (the intellectual level of the internal image of disorder). With time, their self-confidence and the ability to get rid of pain was decreasing (R = -0.32, p = 0.02). The decrease looked like waning fluctuations with a maximum decline rate in the second year of the disease. Conclusion: During the first year from the disease manifestation, patients with nociceptive pain are convinced that they have all necessary resources to cope with the disease; mandatory psychological support should be provided to them in the second year, with a dramatic drop of their self-efficacy. As for patients with mixed types of pain, the inclusion of sessions with a medical psychologist into their individual rehabilitation plan is advisable regardless of the duration of the pain syndrome.
理由:疼痛是所有疾病中最普遍的症状,其中背部疼痛占12%至33%。慢性背痛在致残原因中排名第四。大约60%的慢性疼痛患者有抑郁症状。然而,缺乏关于背痛患者疼痛综合征的心理方面的经验数据。目的:探讨慢性腰痛患者内部紊乱影像的暂时性转变。材料和方法:在这项观察性队列分析研究中,我们评估了84例由背部病变引起的慢性疼痛持续长达55年的患者,疼痛持续时间对疾病内部形象形成的影响。患者(女性53例,男性31例,年龄23 ~ 86岁,疼痛强度可达中等程度)为住院二级医学康复患者。障碍的内在意象采用以下心理测量量表进行操作:麦吉尔疼痛问卷、控制源恢复量表、坦帕运动恐惧症量表和疾病态度心理因素及其治疗量表。结果:障碍内象感觉水平表现为混合性(神经性和功能失调性)疼痛29例(34.5%),痛觉性疼痛55例(65.5%)。在痛觉性疼痛患者中,疼痛持续时间与他们对疾病的自我效能感(疾病内部形象的智力水平)呈负相关。随着时间的推移,他们的自信心和摆脱痛苦的能力逐渐下降(R = -0.32, p = 0.02)。这种下降看起来像是在疾病的第二年以最大的下降率逐渐减弱的波动。结论:在疾病出现后的第一年,痛觉性疼痛患者确信自己有一切必要的资源来应对疾病;在第二年应该对他们进行强制性的心理支持,他们的自我效能感会急剧下降。对于混合型疼痛的患者,无论疼痛综合征持续多久,建议将与医学心理学家的会面纳入其个人康复计划。
{"title":"Time-dependent transformations of the internal image of disorder in patients with chronic back pain","authors":"A. V. Kotelnikova, A. Kukshina, Anastasia S. Tikhonova, Anna V. Khaustova","doi":"10.18786/2072-0505-2022-50-046","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-046","url":null,"abstract":"Rationale: Pain is the most prevalent symptom of any disease, with back pain comprising 12 to 33%. Chronic back pain ranges fourth among the causes of disability. About 60% of patients with chronic pain have symptoms of depression. However, there is paucity of empirical data on psychological aspects of the pain syndrome chronization in patients with back pain. \u0000Aim: To study the temporary transformation of the internal image of disorder in patients with chronic back pain. \u0000Materials and methods: In this observational cohort analytical study, we evaluated the contribution of pain duration into the formation of the internal image of disorder in 84 patients with chronic pain lasting for up to 55 years and caused by dorsopathy. The patients (53 women and 31 men aged 23 to 86 years, with pain intensity of up to moderate degree) were those admitted to an in-patient department for the secondary medical rehabilitation. The internal image of disorder was operationalized with the following psychometric scales: McGill Pain Questionnaire, the Restoration of the Locus of Control Scale, the Tampa Scale of Kinesiophobia, and the Psychological Factors of Attitudes to the Disease and its Treatment Scale. \u0000Results: The sensory level of the internal image of disorder was characterized by mixed (neuropathic and dysfunctional) pain in 29 (34.5%) of the cases and nociceptive pain in 55 (65.5%) of the cases. In the patients with nociceptive pain, the duration of pain was negatively correlated with their perception of self-efficacy towards the disease (the intellectual level of the internal image of disorder). With time, their self-confidence and the ability to get rid of pain was decreasing (R = -0.32, p = 0.02). The decrease looked like waning fluctuations with a maximum decline rate in the second year of the disease. \u0000Conclusion: During the first year from the disease manifestation, patients with nociceptive pain are convinced that they have all necessary resources to cope with the disease; mandatory psychological support should be provided to them in the second year, with a dramatic drop of their self-efficacy. As for patients with mixed types of pain, the inclusion of sessions with a medical psychologist into their individual rehabilitation plan is advisable regardless of the duration of the pain syndrome.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86413509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Unverricht-Lundborg disease as a part of the progressive myoclonic epilepsies syndrome Unverricht-Lundborg病是进行性肌阵挛性癫痫综合征的一部分
Pub Date : 2022-11-21 DOI: 10.18786/2072-0505-2022-50-041
E. Belousova
The progressive myoclonic epilepsies syndrome (PME) is a heterogeneous group of genetic disorders characterized by myoclonus, progressive motor and cognitive abnormalities, sensory and cerebellar symptoms, abnormal slowing of the basic bioelectrical activity at electroencephalography, and normal cognitive functions and normal development of the patient before manifestation of the disease. Generalized spike-wave complexes at electroencephalography have been also described as an obligatory symptom. The Unverricht-Lundborg disease is a distinct entity within the group with specific age at manifestation (7 to 13 years), as well as slow cognitive and motor decline with stabilization in the adult age. In 90% of the cases, the diagnosis is confirmed by identification of the expanded nucleotide duplicates in the CSTB gene. An adequately tailored anticonvulsant treatment can stabilize and improve the patient's condition. The anticonvulsant therapy should not include sodium channel blockers. Valproate sodium is considered to be the main agent; it is usually combined with levetiracetam/zonisamide/topiramate/benzodiazepins. In the recent years, perampanel has been also used as a part of the combination treatment.
进行性肌阵挛性癫痫综合征(PME)是一种异质性遗传疾病,其特征是肌阵挛、进行性运动和认知异常、感觉和小脑症状、脑电图基本生物电活动异常减慢,以及患者在疾病表现前的正常认知功能和正常发育。脑电图上的广义尖波复合体也被描述为一种强制性症状。Unverricht-Lundborg病在该群体中是一个独特的实体,具有特定的表现年龄(7至13岁),以及缓慢的认知和运动衰退,并在成年期趋于稳定。在90%的病例中,通过鉴定CSTB基因扩增的核苷酸重复来确诊。适当的抗惊厥药物治疗可以稳定和改善患者的病情。抗惊厥治疗不应包括钠通道阻滞剂。丙戊酸钠被认为是主要药物;通常与左乙拉西坦/唑尼沙胺/托吡酯/苯二氮卓类药物合用。近年来,perampanel也被用作组合处理的一部分。
{"title":"The Unverricht-Lundborg disease as a part of the progressive myoclonic epilepsies syndrome","authors":"E. Belousova","doi":"10.18786/2072-0505-2022-50-041","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-041","url":null,"abstract":"The progressive myoclonic epilepsies syndrome (PME) is a heterogeneous group of genetic disorders characterized by myoclonus, progressive motor and cognitive abnormalities, sensory and cerebellar symptoms, abnormal slowing of the basic bioelectrical activity at electroencephalography, and normal cognitive functions and normal development of the patient before manifestation of the disease. Generalized spike-wave complexes at electroencephalography have been also described as an obligatory symptom. The Unverricht-Lundborg disease is a distinct entity within the group with specific age at manifestation (7 to 13 years), as well as slow cognitive and motor decline with stabilization in the adult age. In 90% of the cases, the diagnosis is confirmed by identification of the expanded nucleotide duplicates in the CSTB gene. An adequately tailored anticonvulsant treatment can stabilize and improve the patient's condition. The anticonvulsant therapy should not include sodium channel blockers. Valproate sodium is considered to be the main agent; it is usually combined with levetiracetam/zonisamide/topiramate/benzodiazepins. In the recent years, perampanel has been also used as a part of the combination treatment.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75499270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Сognitive rehabilitation methods in multiple sclerosis patients Сognitive多发性硬化症患者的康复方法
Pub Date : 2022-11-21 DOI: 10.18786/2072-0505-2022-50-043
E. Moskvina, L. Volkova, O. Koryakina
The prevalence of cognitive impairment in patients with multiple sclerosis is 40 to 65%. Improvement of cognitive-oriented therapy and search for its new techniques is considered to be promising for slowing the progression or for recovery of cognitive functions. It is related to low efficacy of medical treatment, preserved neuroplasticity in most patients with multiple sclerosis, positive results of studies on selected cognitive rehabilitation techniques in other nervous system disorders. The spectrum of techniques for cognitive training varies from technically feasible methods using a sheet of paper and a pen to the most advanced ones, such as the use of immersive virtual reality. The effectiveness of cognitive rehabilitation in patients with multiple sclerosis with virtual reality technologies has not been studied in large-scale randomized placebo-controlled studies.
多发性硬化症患者的认知障碍患病率为40%至65%。认知导向疗法的改进和新技术的探索被认为对减缓认知功能的进展或恢复有希望。这与药物治疗的低疗效、大多数多发性硬化症患者保留神经可塑性、其他神经系统疾病的选择性认知康复技术研究的积极结果有关。认知训练的技术范围各不相同,从技术上可行的使用一张纸和一支笔的方法到最先进的方法,如使用沉浸式虚拟现实。虚拟现实技术对多发性硬化症患者认知康复的有效性尚未在大规模随机安慰剂对照研究中进行研究。
{"title":"Сognitive rehabilitation methods in multiple sclerosis patients","authors":"E. Moskvina, L. Volkova, O. Koryakina","doi":"10.18786/2072-0505-2022-50-043","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-043","url":null,"abstract":"The prevalence of cognitive impairment in patients with multiple sclerosis is 40 to 65%. Improvement of cognitive-oriented therapy and search for its new techniques is considered to be promising for slowing the progression or for recovery of cognitive functions. It is related to low efficacy of medical treatment, preserved neuroplasticity in most patients with multiple sclerosis, positive results of studies on selected cognitive rehabilitation techniques in other nervous system disorders. The spectrum of techniques for cognitive training varies from technically feasible methods using a sheet of paper and a pen to the most advanced ones, such as the use of immersive virtual reality. The effectiveness of cognitive rehabilitation in patients with multiple sclerosis with virtual reality technologies has not been studied in large-scale randomized placebo-controlled studies.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73085770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of the follow-up and treatment of patients with acromegaly with the SAGIT® tool SAGIT®工具对肢端肥大症患者随访和治疗的优化
Pub Date : 2022-11-17 DOI: 10.18786/2072-0505-2022-50-042
I. Ilovayskaya
The condition of a patient with acromegaly is significantly influenced not only by growth hormone (GH) and insulin-like growth factor type 1 (IGF-1) levels, but also by specific characteristics of somatotropinoma, severity of the main symptoms of acromegaly, and concomitant disorders. After successful achievement of biochemical control (GH and IGF-1 goals) the expected life longevity in patients with acromegaly could be comparable with that in the general population. It is important to avoid therapeutic inertia, to achieve biochemical control within shortest time period and to carefully tailor the treatment of concomitant disorders. The cumulative experience of patient management has shown that therapeutic decisions should be based not only on measurement of GH and IGF-1 levels, but also on a unified multifactorial assessment of the patient's status. For this purpose, the SAGIT tool has been elaborated, which ensures a multifaceted standardized assessment of patients with acromegaly, taking into account clinical symptoms, hormonal parameters, tumor size and comorbidities. This paper is the first description of the SAGIT tool in Russian. The use of this tool allows for standardization of the patients assessment and for comparison of the status in patients both within one center and in different centers. The key unified information obtained with SAGIT could be the basis for making prompt decisions on the need in treatment optimization for a patient with acromegaly, including his/hers referral to an expert center for the choice of further treatment strategy. The SAGIT tool has been recommended for implementation into clinical practice by international professional associations. It is advisable to perform studies with participation of the Russian patients with acromegaly to assess the possibility of SAGIT implementation into clinical practice in Russia.
肢端肥大症患者的病情不仅受生长激素(GH)和胰岛素样生长因子1型(IGF-1)水平的显著影响,还受生长激素瘤的特定特征、肢端肥大症主要症状的严重程度以及伴随疾病的影响。成功实现生化控制(GH和IGF-1目标)后,肢端肥大症患者的预期寿命可与普通人群相当。重要的是避免治疗惰性,在最短的时间内实现生化控制,并仔细定制治疗伴随疾病。患者管理的累积经验表明,治疗决策不仅应基于生长激素和IGF-1水平的测量,还应基于对患者状态的统一多因素评估。为此,制定了SAGIT工具,确保对肢端肥大症患者进行多方面的标准化评估,同时考虑到临床症状、激素参数、肿瘤大小和合并症。本文是对俄语SAGIT工具的首次描述。使用该工具可以使患者评估标准化,并对同一中心和不同中心的患者状况进行比较。通过SAGIT获得的关键统一信息可以作为肢端肥大症患者及时做出治疗优化决策的基础,包括转介到专家中心选择进一步的治疗策略。SAGIT工具已被国际专业协会推荐用于临床实践。建议在俄罗斯肢端肥大症患者的参与下进行研究,以评估SAGIT在俄罗斯临床实践中实施的可能性。
{"title":"Optimization of the follow-up and treatment of patients with acromegaly with the SAGIT® tool","authors":"I. Ilovayskaya","doi":"10.18786/2072-0505-2022-50-042","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-042","url":null,"abstract":"The condition of a patient with acromegaly is significantly influenced not only by growth hormone (GH) and insulin-like growth factor type 1 (IGF-1) levels, but also by specific characteristics of somatotropinoma, severity of the main symptoms of acromegaly, and concomitant disorders. After successful achievement of biochemical control (GH and IGF-1 goals) the expected life longevity in patients with acromegaly could be comparable with that in the general population. It is important to avoid therapeutic inertia, to achieve biochemical control within shortest time period and to carefully tailor the treatment of concomitant disorders. \u0000The cumulative experience of patient management has shown that therapeutic decisions should be based not only on measurement of GH and IGF-1 levels, but also on a unified multifactorial assessment of the patient's status. For this purpose, the SAGIT tool has been elaborated, which ensures a multifaceted standardized assessment of patients with acromegaly, taking into account clinical symptoms, hormonal parameters, tumor size and comorbidities. This paper is the first description of the SAGIT tool in Russian. The use of this tool allows for standardization of the patients assessment and for comparison of the status in patients both within one center and in different centers. The key unified information obtained with SAGIT could be the basis for making prompt decisions on the need in treatment optimization for a patient with acromegaly, including his/hers referral to an expert center for the choice of further treatment strategy. \u0000The SAGIT tool has been recommended for implementation into clinical practice by international professional associations. It is advisable to perform studies with participation of the Russian patients with acromegaly to assess the possibility of SAGIT implementation into clinical practice in Russia.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78811192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Romberg's sign: from walking in the dark to tests on the force plate 龙伯格的标志:从在黑暗中行走到在测力板上测试
Pub Date : 2022-11-17 DOI: 10.18786/2072-0505-2022-50-040
Anastasia I. Mezenchuk, O. Kubryak
A quantitative assessment of stability (body balance, equilibrium) and sensory support of the upright position, with identification of the "contributions" from various sensory systems, is the basis for the force plate tests similar to the Romberg's test. The purpose of this paper is to describe the Romberg's test evolution from its introduction to objective quantitative force plate tests (stabilometry) in the context of studies into the sensory support of the upright position in humans. The use of force plates for quantitative characterization of the body balance in the upright position with changing sensory conditions has added a higher sensitivity and accuracy to this assessment, providing for a more precise differentiation of various conditions. The tests originating from the Romberg's one but performed on a force plate can be considered as a quantitative investigation into the functioning of the sensory systems participating in the support of the upright position, as well as a tool for the assessment of their isolated contributions and central integration. The value of such tests for clinical medicine is related to a higher level of verification of the body balance abnormalities in various disorders, with an improvement of diagnosis and potential for differential diagnosis. With these assessments being non-invasive, it is feasible to use them for evaluation of changes of the upright equilibrium over time under treatment and rehabilitation procedures in neurology, traumatology and orthopedics, otolaryngology, sports medicine and other areas.
稳定性(身体平衡,平衡)和直立位置的感觉支持的定量评估,并识别来自各种感觉系统的“贡献”,是类似Romberg测试的力板测试的基础。本文的目的是在研究人类直立位置的感觉支持的背景下,描述Romberg测试从其引入到客观定量力板测试(稳定测量)的演变。使用力板定量表征直立位置随感官条件变化的身体平衡,为该评估增加了更高的灵敏度和准确性,提供了更精确的各种条件的区分。源自Romberg的测试,但在力板上进行的测试可以被认为是对参与支持直立位置的感觉系统功能的定量调查,以及评估其孤立贡献和中心整合的工具。这类检测对临床医学的价值在于对各种疾病的身体平衡异常有更高水平的验证,具有提高诊断和鉴别诊断的潜力。由于这些评估是非侵入性的,因此可以用于评估神经病学、创伤学和骨科、耳鼻喉科、运动医学等领域的治疗和康复过程中直立平衡随时间的变化。
{"title":"The Romberg's sign: from walking in the dark to tests on the force plate","authors":"Anastasia I. Mezenchuk, O. Kubryak","doi":"10.18786/2072-0505-2022-50-040","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-040","url":null,"abstract":"A quantitative assessment of stability (body balance, equilibrium) and sensory support of the upright position, with identification of the \"contributions\" from various sensory systems, is the basis for the force plate tests similar to the Romberg's test. The purpose of this paper is to describe the Romberg's test evolution from its introduction to objective quantitative force plate tests (stabilometry) in the context of studies into the sensory support of the upright position in humans. The use of force plates for quantitative characterization of the body balance in the upright position with changing sensory conditions has added a higher sensitivity and accuracy to this assessment, providing for a more precise differentiation of various conditions. The tests originating from the Romberg's one but performed on a force plate can be considered as a quantitative investigation into the functioning of the sensory systems participating in the support of the upright position, as well as a tool for the assessment of their isolated contributions and central integration. The value of such tests for clinical medicine is related to a higher level of verification of the body balance abnormalities in various disorders, with an improvement of diagnosis and potential for differential diagnosis. With these assessments being non-invasive, it is feasible to use them for evaluation of changes of the upright equilibrium over time under treatment and rehabilitation procedures in neurology, traumatology and orthopedics, otolaryngology, sports medicine and other areas.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83500648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of the traumatic factor and isomorphic reaction in the early diagnosis of psoriatic arthritis 创伤因素及同构反应在银屑病关节炎早期诊断中的作用
Pub Date : 2022-11-10 DOI: 10.18786/2072-0505-2022-50-030
K. M. Koreshkova, Z. Khismatullina
Rationale: Evaluation of the role of the deep Koebner's phenomenon and traumatization seems to be a promising direction in the search of the solution for the delayed diagnosis of psoriatic arthritis (PsA) in patients with psoriasis. We have put forward the question if joint and ligament abnormalities induced by a trauma or persistent physical activity could be an analogue of the skin isomorphic reaction in psoriasis. Aim: To identify joint and ligament abnormalities in patients with psoriasis caused by mechanical stress and their association with the deep Koebner's phenomenon and PsA. Materials and methods: This was an open-label, non-randomized, comparative study in parallel groups in 80 in-patients with psoriasis (recruited in the Dermatovenereological clinic № 1, Ufa); the control group included 80 in-patients with PsA. All patients were assessed by a dermatovenereologist, including past history, severity of psoriasis, degree of PsA activity, special questionnaires and the presence of an isomorphic reaction in the skin and periarticular tissues. The joints with maximal physical activity were assessed by X-ray. PsA was diagnosed by a rheumatologist. Results: The patients from both groups were matched in terms of age, gender, and duration of psoriasis. Pain, joint stiffness and limitation of mobility were present not only in the PsA group, but also in the patients with psoriasis (35%, 27.5% and 26.2% of the patients, respectively). Despite most of the patients in the psoriasis group had no active complaints (65.0% vs. 0% in the control group, p 0.001), clinical signs of inflammation of the tendons and entheses and relevant history were found in 47.5% (68.7% in the control group, p = 0.007). Hand tendinitis was most prevalent symptom in both groups: 40.0% (32/80) in the psoriasis group and 63.7% (51/80) in the PsA group (p = 0.003). Achilles tendon lesions were found in 17.5% (14/80) and 52.5% (42/80) (p 0.001) and periarticular edema in 27.5% (22/80) and 63.7% (51/80), respectively (p 0.001). The combination of these signs with psoriatic plaques in this area was observed in 32.5% (26/80) and 92.5% (74/80) of the patients, respectively (p 0.001). The comparison of the clinical and X-ray data showed that 38 patients with psoriasis and newly diagnosed PsA had had an increased physical load on the affected joints, as well as signs of a deep isomorphic reaction (tendinitis, periarticular edema, or enthesitis near the involved joints). In both groups, the most common form of PsA was distal one (63.2% [24/38] of the patients with newly diagnosed PsA and 58.7% [47/80] of the patients with previously diagnosed PsA, p = 0.648). Conclusion: Involvement of the periarticular tissues, as well as early, including preclinical, X-ray abnormalities in the joints of patients with psoriasis can be associated with increased physical activity and the deep Koebner's phenomenon. Therefore, even if patients with psoriasis do not have any clinical manifestations of P
理论基础:评价深部Koebner现象和创伤的作用似乎是寻找银屑病患者银屑病关节炎(PsA)延迟诊断解决方案的一个有希望的方向。我们提出了一个问题,如果关节和韧带异常引起的创伤或持续的体力活动可能是一个类似的皮肤同构反应在牛皮癣。目的:探讨机械应力引起的银屑病患者关节韧带异常及其与深部Koebner现象和PsA的关系。材料和方法:这是一项开放标签,非随机,平行组80例银屑病住院患者的比较研究(在乌法1号皮肤性病诊所招募);对照组包括80例住院PsA患者。所有患者均由皮肤性病专家进行评估,包括既往病史、牛皮癣严重程度、PsA活性程度、特殊问卷调查以及皮肤和关节周围组织中是否存在同构反应。用x线对最大活动量关节进行评估。PsA是由风湿病学家诊断的。结果:两组患者在年龄、性别和牛皮癣病程方面相匹配。疼痛、关节僵硬和活动受限不仅存在于PsA组,也存在于银屑病患者中(分别占35%、27.5%和26.2%)。尽管银屑病组大多数患者无主诉(65.0% vs.对照组0%,p = 0.001),但47.5%的患者有肌腱和肌腱囊炎症的临床症状及相关病史(对照组68.7%,p = 0.007)。两组患者中最常见的症状为手部肌腱炎:银屑病组40.0% (32/80),PsA组63.7% (51/80)(p = 0.003)。跟腱病变发生率分别为17.5%(14/80)和52.5% (42/80)(p 0.001),关节周围水肿发生率分别为27.5%(22/80)和63.7% (51/80)(p 0.001)。分别有32.5%(26/80)和92.5%(74/80)的患者同时出现这些症状(p < 0.001)。临床和x线资料的比较显示,38例银屑病和新诊断的PsA患者受影响关节的物理负荷增加,并且有深部同形反应的迹象(肌腱炎、关节周围水肿或受累关节附近的脓肿)。在两组中,最常见的PsA形式为远端PsA(63.2%[24/38]的新诊断PsA和58.7%[47/80]的既往诊断PsA, p = 0.648)。结论:银屑病患者关节的x线异常累及关节周围组织,以及早期包括临床前的关节异常,可能与体力活动增加和深部Koebner现象有关。因此,即使银屑病患者没有PsA的任何临床表现,在皮肤科医生就诊时也没有抱怨,也建议详细收集病史资料,澄清身体活动类型和过去的创伤,并通过检查和触诊检查关节周围组织(肌腱和肌腱),以便及时使用x线检查。风湿病专家会诊,目的是诊断银屑病关节炎。
{"title":"The role of the traumatic factor and isomorphic reaction in the early diagnosis of psoriatic arthritis","authors":"K. M. Koreshkova, Z. Khismatullina","doi":"10.18786/2072-0505-2022-50-030","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-030","url":null,"abstract":"Rationale: Evaluation of the role of the deep Koebner's phenomenon and traumatization seems to be a promising direction in the search of the solution for the delayed diagnosis of psoriatic arthritis (PsA) in patients with psoriasis. We have put forward the question if joint and ligament abnormalities induced by a trauma or persistent physical activity could be an analogue of the skin isomorphic reaction in psoriasis. \u0000Aim: To identify joint and ligament abnormalities in patients with psoriasis caused by mechanical stress and their association with the deep Koebner's phenomenon and PsA. \u0000Materials and methods: This was an open-label, non-randomized, comparative study in parallel groups in 80 in-patients with psoriasis (recruited in the Dermatovenereological clinic № 1, Ufa); the control group included 80 in-patients with PsA. All patients were assessed by a dermatovenereologist, including past history, severity of psoriasis, degree of PsA activity, special questionnaires and the presence of an isomorphic reaction in the skin and periarticular tissues. The joints with maximal physical activity were assessed by X-ray. PsA was diagnosed by a rheumatologist. \u0000Results: The patients from both groups were matched in terms of age, gender, and duration of psoriasis. Pain, joint stiffness and limitation of mobility were present not only in the PsA group, but also in the patients with psoriasis (35%, 27.5% and 26.2% of the patients, respectively). Despite most of the patients in the psoriasis group had no active complaints (65.0% vs. 0% in the control group, p 0.001), clinical signs of inflammation of the tendons and entheses and relevant history were found in 47.5% (68.7% in the control group, p = 0.007). Hand tendinitis was most prevalent symptom in both groups: 40.0% (32/80) in the psoriasis group and 63.7% (51/80) in the PsA group (p = 0.003). Achilles tendon lesions were found in 17.5% (14/80) and 52.5% (42/80) (p 0.001) and periarticular edema in 27.5% (22/80) and 63.7% (51/80), respectively (p 0.001). The combination of these signs with psoriatic plaques in this area was observed in 32.5% (26/80) and 92.5% (74/80) of the patients, respectively (p 0.001). The comparison of the clinical and X-ray data showed that 38 patients with psoriasis and newly diagnosed PsA had had an increased physical load on the affected joints, as well as signs of a deep isomorphic reaction (tendinitis, periarticular edema, or enthesitis near the involved joints). In both groups, the most common form of PsA was distal one (63.2% [24/38] of the patients with newly diagnosed PsA and 58.7% [47/80] of the patients with previously diagnosed PsA, p = 0.648). \u0000Conclusion: Involvement of the periarticular tissues, as well as early, including preclinical, X-ray abnormalities in the joints of patients with psoriasis can be associated with increased physical activity and the deep Koebner's phenomenon. Therefore, even if patients with psoriasis do not have any clinical manifestations of P","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74820306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The successful selective His bundle pacing to the patient with permanent atrial fibrillation 对永久性房颤患者进行选择性His束起搏成功
Pub Date : 2022-11-10 DOI: 10.18786/2072-0505-2022-50-039
Sergey S. Zamudriakov, E. A. Ivanitskiy, A. A. Vyrva, V. A. Sakovich, D. B. Drobot
The choice of an optimal, most safe and physiological place in the heart for the electrode implantation is an issue to be solved by a specialist in surgery of heart arrhythmias. According to the literature, the techniques to stimulate both cardiac apex and other alternative areas are imperfect. At present, stimulation of the heart conduction system, namely, the His bundle is considered a promising area in arrhythmology. This type of stimulation is a physiological one, while it involves the His-Purkinje system. We present a successful clinical case of the electrode implantation with a two-chamber pacemaker to the heart conduction system in a 67-year-old patient with permanent atrial fibrillation. The surgical intervention made it possible to reduce the QRS length from 180 to 110 ms. This clinical case shows that the heart conduction system pacing allows for implementation of the principles of physiological stimulation in patients with impaired atrioventricular conduction. The technique with a two-chamber pacemaker is feasible in clinical practice.
在心脏中选择一个最理想、最安全、最生理的位置进行电极植入是心律失常外科专家需要解决的问题。根据文献,刺激心尖和其他替代区域的技术是不完善的。目前,刺激心脏传导系统,即贺氏束被认为是心律失常学中一个有前途的领域。这种类型的刺激是一种生理刺激,而它涉及到他-浦肯野系统。我们提出了一个成功的临床案例电极植入与双室起搏器心脏传导系统在一个67岁的患者永久性心房颤动。手术干预使QRS长度从180 ms减少到110 ms成为可能。本临床病例表明,心脏传导系统起搏允许在房室传导受损的患者中实施生理刺激原则。双腔起搏器技术在临床实践中是可行的。
{"title":"The successful selective His bundle pacing to the patient with permanent atrial fibrillation","authors":"Sergey S. Zamudriakov, E. A. Ivanitskiy, A. A. Vyrva, V. A. Sakovich, D. B. Drobot","doi":"10.18786/2072-0505-2022-50-039","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-039","url":null,"abstract":"The choice of an optimal, most safe and physiological place in the heart for the electrode implantation is an issue to be solved by a specialist in surgery of heart arrhythmias. According to the literature, the techniques to stimulate both cardiac apex and other alternative areas are imperfect. At present, stimulation of the heart conduction system, namely, the His bundle is considered a promising area in arrhythmology. This type of stimulation is a physiological one, while it involves the His-Purkinje system. We present a successful clinical case of the electrode implantation with a two-chamber pacemaker to the heart conduction system in a 67-year-old patient with permanent atrial fibrillation. The surgical intervention made it possible to reduce the QRS length from 180 to 110 ms. This clinical case shows that the heart conduction system pacing allows for implementation of the principles of physiological stimulation in patients with impaired atrioventricular conduction. The technique with a two-chamber pacemaker is feasible in clinical practice.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81106244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulators of angiogenesis in chemotherapy-induced peripheral neuropathy 化疗诱导的周围神经病变血管生成的调节因子
Pub Date : 2022-10-27 DOI: 10.18786/2072-0505-2022-50-038
V. Bazarnyi, O. Kovtun, O. Koryakina, M. Kopenkin, L. Fechina
Background: Chemotherapy-induced peripheral polyneuropathy is a major neurotoxicity of treatment for acute lymphoblastic leukemia (ALL) in children. Pathophysiological mechanisms of the injury of peripheral neural system are not fully investigated; however, some studies have shown the involvement of vascular endothelial growth factors. Aim: To evaluate plasma levels of angiogenic growth factors in children with ALL and to identify their association with the development of vincristine-induced peripheral polyneuropathy. Materials and methods: This single center prospective study included 41 patients with ALL aged 3 to 17 years. All patients were given the ALL-MB 2015 chemotherapy regimen. Depending on the vincristine-induced peripheral polyneuropathy, the patients were divided into two groups: the main group (n = 22) comprised of the patients with neurological signs and symptoms of peripheral neuropathy and the control group (n = 19), those without clinical signs of the peripheral nervous system involvement. The levels of angiogenic growth factors (VEGF-A, VEGF-D, PlGF-1, and PDGF-BB) were measured in plasma by multiparameter immunofluorescent analysis. Results: During 3 months of the follow up the chemotherapy-induced signs of peripheral polyneuropathy developed in 53.6% (n = 22) of the children. In 72.7% (n = 16) of the patients the chemotherapy-induced peripheral polyneuropathy was characterized by a combination of neurologic abnormalities with prevailing motor symptoms. The comparative analysis of plasma angiogenic growth factors in children with ALL depending on the presence or absence of the vincristine-induced peripheral polyneuropathy showed that there was a significant decrease of the VEGF-A in those with chemotherapy-induced peripheral polyneuropathy, compared to those without (Me [Q1; Q3]: 178.20 [138.40; 228.45] and 558.50 [160.10; 650.0], respectively, p 0.017). This parameter had diagnostic sensitivity of 77.7% and specificity of 76.9%. Conclusion: We have shown a high clinical value of plasma vascular endothelial growth factor (VEGF-A) level, which makes it possible to consider it as a significant biological marker of neurotoxicity in vincristine-induced peripheral polyneuropathy.
背景:化疗诱导的周围多神经病变是儿童急性淋巴细胞白血病(ALL)治疗的主要神经毒性。外周神经系统损伤的病理生理机制尚不清楚;然而,一些研究表明血管内皮生长因子参与其中。目的:评价ALL患儿血浆血管生成生长因子水平,并确定其与长春新碱诱导的周围多发性神经病变的关系。材料和方法:本单中心前瞻性研究纳入41例3 - 17岁ALL患者。所有患者均给予All - mb 2015化疗方案。根据长春新碱引起的周围多神经病变的不同,将患者分为两组:主组(n = 22)为有神经体征和周围神经病变症状的患者,对照组(n = 19)为无周围神经系统受累临床体征的患者。采用多参数免疫荧光法测定血浆中血管生成生长因子(VEGF-A、VEGF-D、PlGF-1和PDGF-BB)的水平。结果:在3个月的随访中,53.6% (n = 22)的儿童出现了化疗引起的周围多发性神经病变迹象。在72.7% (n = 16)的患者中,化疗引起的周围多神经病变的特征是神经系统异常与主要运动症状的结合。根据长春新碱诱导的周围多发性神经病变存在与否对ALL患儿血浆血管生成生长因子的比较分析显示,化疗诱导的周围多发性神经病变患者的VEGF-A明显低于无化疗诱导的周围多发性神经病变患者(Me [Q1;[3]: 178.20 [138.40;228.45]和558.50 [160.10;650.0], p 0.017)。该参数诊断敏感性为77.7%,特异性为76.9%。结论:血浆血管内皮生长因子(VEGF-A)水平具有较高的临床价值,可作为长春新碱诱导的周围多发性神经病神经毒性的重要生物学标志物。
{"title":"Regulators of angiogenesis in chemotherapy-induced peripheral neuropathy","authors":"V. Bazarnyi, O. Kovtun, O. Koryakina, M. Kopenkin, L. Fechina","doi":"10.18786/2072-0505-2022-50-038","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-038","url":null,"abstract":"Background: Chemotherapy-induced peripheral polyneuropathy is a major neurotoxicity of treatment for acute lymphoblastic leukemia (ALL) in children. Pathophysiological mechanisms of the injury of peripheral neural system are not fully investigated; however, some studies have shown the involvement of vascular endothelial growth factors. \u0000Aim: To evaluate plasma levels of angiogenic growth factors in children with ALL and to identify their association with the development of vincristine-induced peripheral polyneuropathy. \u0000Materials and methods: This single center prospective study included 41 patients with ALL aged 3 to 17 years. All patients were given the ALL-MB 2015 chemotherapy regimen. Depending on the vincristine-induced peripheral polyneuropathy, the patients were divided into two groups: the main group (n = 22) comprised of the patients with neurological signs and symptoms of peripheral neuropathy and the control group (n = 19), those without clinical signs of the peripheral nervous system involvement. The levels of angiogenic growth factors (VEGF-A, VEGF-D, PlGF-1, and PDGF-BB) were measured in plasma by multiparameter immunofluorescent analysis. \u0000Results: During 3 months of the follow up the chemotherapy-induced signs of peripheral polyneuropathy developed in 53.6% (n = 22) of the children. In 72.7% (n = 16) of the patients the chemotherapy-induced peripheral polyneuropathy was characterized by a combination of neurologic abnormalities with prevailing motor symptoms. The comparative analysis of plasma angiogenic growth factors in children with ALL depending on the presence or absence of the vincristine-induced peripheral polyneuropathy showed that there was a significant decrease of the VEGF-A in those with chemotherapy-induced peripheral polyneuropathy, compared to those without (Me [Q1; Q3]: 178.20 [138.40; 228.45] and 558.50 [160.10; 650.0], respectively, p 0.017). This parameter had diagnostic sensitivity of 77.7% and specificity of 76.9%. \u0000Conclusion: We have shown a high clinical value of plasma vascular endothelial growth factor (VEGF-A) level, which makes it possible to consider it as a significant biological marker of neurotoxicity in vincristine-induced peripheral polyneuropathy.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90866164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics and efficacy of acromegaly treatment in the Udmurt Republic 乌德穆尔特共和国肢端肥大症治疗的临床特点和疗效
Pub Date : 2022-10-26 DOI: 10.18786/2072-0505-2022-50-037
G. Nurullina, G. I. Akhmadullina, I. S. Maslova, Alexandra R. Nikolaeva
Background: Acromegaly is a severe neuroendocrine disorder caused by chronic overproduction of growth hormone and insulin-like growth factor 1 and associated with a variety of clinical manifestations, debilitating complications and progressive disability, if no biochemical control has been achieved. The Russian registry of hypothalamic-pituitary tumors allows for evaluation of the epidemiological, demographic and clinical characteristics of patients with acromegaly, as well as of the effectiveness of various treatment methods. Aim: To identify epidemiological and clinical characteristics and treatment efficacy for acromegaly in the patients in the Udmurt Republic. Materials and methods: We performed a cross-sectional study based on the registry of hypothalamic-pituitary tumors of the Udmurt Republic as per June 2022. It contains data from 77 patients with acromegaly. The study included 59 (76.62%) patients with the information sufficient for evaluation of the disease stage and its complications. Results: According to the registry of hypothalamic-pituitary tumors, the prevalence of acromegaly in the Udmurt Republic was 6.71 cases per 100,000 of the population. Patients with acromegaly in Udmurt Republic had a high prevalence of arthralgia, abnormally large feet and hands, weakness/fatigue, snoring / sleep apnea, increased sweating, dizziness, peripheral edema, obesity, menstrual cycle abnormalities, diabetes mellitus, nodular goiter, pathological fractures and hypopituitarism. Neurosurgery has been performed in 74.57% (n = 44) of the patients, with a remission of acromegaly achieved in 18 (40.9%). Medical treatment was given to 25/59 (42.37%) of the patients, with 22 of them being treated with 1st generation long-acting somatostatin analogues. Radiation therapy has been administered to 13 patients (22.03%). Biochemical control was achieved in 40/59 (67.8%) of patients with acromegaly, related to neurosurgery in most patients, as well as to the use of a growth hormone receptor antagonist and/or combined medical treatment. Conclusion: The prevalence of acromegaly in the Udmurt Republic is consistent with international data. Clinical characteristics of acromegaly generally correspond to the classic disease course, although a number of symptoms are more commonly found in the Udmurt Republic patients than in the Russian Federation registry; this might be related to the quality of the registry management. The effectiveness of treatment for acromegaly in Udmurt Republic is comparable to the international data.
背景:肢端肥大症是一种严重的神经内分泌疾病,由生长激素和胰岛素样生长因子1的慢性过量产生引起,如果没有生化控制,可伴有多种临床表现、衰弱并发症和进行性残疾。俄罗斯下丘脑-垂体肿瘤登记处允许评估肢端肥大症患者的流行病学、人口学和临床特征,以及各种治疗方法的有效性。目的:了解乌德穆尔特共和国肢端肥大症患者的流行病学、临床特点及治疗效果。材料和方法:我们根据2022年6月乌德穆尔特共和国下丘脑垂体肿瘤的登记进行了一项横断面研究。它包含了77例肢端肥大症患者的数据。本研究纳入59例(76.62%)患者,资料足以评估疾病分期及其并发症。结果:根据下丘脑-垂体肿瘤登记,乌德穆尔特共和国肢端肥大症的患病率为每10万人6.71例。乌德穆尔特共和国肢端肥大症患者普遍存在关节痛、异常大的脚和手、虚弱/疲劳、打鼾/睡眠呼吸暂停、出汗增多、头晕、周围水肿、肥胖、月经周期异常、糖尿病、结节性甲状腺肿、病理性骨折和垂体功能减退。74.57% (n = 44)的患者接受了神经外科手术,其中18例(40.9%)肢端肥大症得到缓解。59例患者中有25例(42.37%)接受了药物治疗,其中22例接受了第一代长效生长抑素类似物治疗。13例患者(22.03%)接受放射治疗。59例肢端肥大症患者中有40例(67.8%)实现了生化控制,这与大多数患者的神经外科手术以及使用生长激素受体拮抗剂和/或联合药物治疗有关。结论:乌德穆尔特共和国肢端肥大症的患病率与国际数据一致。肢端肥大症的临床特征一般符合典型病程,尽管乌德穆尔特共和国患者的一些症状比俄罗斯联邦登记的患者更常见;这可能与注册中心管理的质量有关。乌德穆尔特共和国肢端肥大症的治疗效果与国际数据相当。
{"title":"Clinical characteristics and efficacy of acromegaly treatment in the Udmurt Republic","authors":"G. Nurullina, G. I. Akhmadullina, I. S. Maslova, Alexandra R. Nikolaeva","doi":"10.18786/2072-0505-2022-50-037","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-037","url":null,"abstract":"Background: Acromegaly is a severe neuroendocrine disorder caused by chronic overproduction of growth hormone and insulin-like growth factor 1 and associated with a variety of clinical manifestations, debilitating complications and progressive disability, if no biochemical control has been achieved. The Russian registry of hypothalamic-pituitary tumors allows for evaluation of the epidemiological, demographic and clinical characteristics of patients with acromegaly, as well as of the effectiveness of various treatment methods. \u0000Aim: To identify epidemiological and clinical characteristics and treatment efficacy for acromegaly in the patients in the Udmurt Republic. \u0000Materials and methods: We performed a cross-sectional study based on the registry of hypothalamic-pituitary tumors of the Udmurt Republic as per June 2022. It contains data from 77 patients with acromegaly. The study included 59 (76.62%) patients with the information sufficient for evaluation of the disease stage and its complications. \u0000Results: According to the registry of hypothalamic-pituitary tumors, the prevalence of acromegaly in the Udmurt Republic was 6.71 cases per 100,000 of the population. Patients with acromegaly in Udmurt Republic had a high prevalence of arthralgia, abnormally large feet and hands, weakness/fatigue, snoring / sleep apnea, increased sweating, dizziness, peripheral edema, obesity, menstrual cycle abnormalities, diabetes mellitus, nodular goiter, pathological fractures and hypopituitarism. Neurosurgery has been performed in 74.57% (n = 44) of the patients, with a remission of acromegaly achieved in 18 (40.9%). Medical treatment was given to 25/59 (42.37%) of the patients, with 22 of them being treated with 1st generation long-acting somatostatin analogues. Radiation therapy has been administered to 13 patients (22.03%). Biochemical control was achieved in 40/59 (67.8%) of patients with acromegaly, related to neurosurgery in most patients, as well as to the use of a growth hormone receptor antagonist and/or combined medical treatment. \u0000Conclusion: The prevalence of acromegaly in the Udmurt Republic is consistent with international data. Clinical characteristics of acromegaly generally correspond to the classic disease course, although a number of symptoms are more commonly found in the Udmurt Republic patients than in the Russian Federation registry; this might be related to the quality of the registry management. The effectiveness of treatment for acromegaly in Udmurt Republic is comparable to the international data.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85964540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive assessment of cardiovascular complications in a patient with type 1 diabetes mellitus, chronic kidney disease and diabetic neuroosteoarthropathy 1型糖尿病、慢性肾病和糖尿病神经骨关节病变患者心血管并发症的综合评估
Pub Date : 2022-10-21 DOI: 10.18786/2072-0505-2022-50-031
O. Bondarenko, Marianna V. Yaroslavceva, A. Y. Tokmakova, G. Galstyan, N. Tarbaeva
The paper presents a clinical case of the patient with long-term poor control of type 1 diabetes mellitus, chronic kidney disease (CKD) and diabetic neurоosteoarthropathy. The characteristics of interest in the clinical case are CKD complications associated with mineral and bone metabolism disorders. Clinical consequences of vascular calcification due to secondary hyperparathyroidism, autonomic and peripheral neuropathy have resulted in cardiovascular complications. We discuss the diagnostic challenges of vascular calcification, as well as the interpretation of diagnostic methods in lower limb arterial disease, and provide evidence for the advantages of alternative treatment of secondary hyperparathyroidism with a selective activator of vitamin D receptors. The important role of CKD in the development of metabolic, structural and hemodynamic disorders in patients with type 1 diabetes mellitus is emphasized.
本文报告1例长期控制不良的1型糖尿病、慢性肾病(CKD)及糖尿病神经骨关节病患者。在临床病例中感兴趣的特征是CKD并发症与矿物质和骨代谢紊乱。继发性甲状旁腺功能亢进、自主神经和周围神经病变引起的血管钙化的临床后果已导致心血管并发症。我们讨论了血管钙化的诊断挑战,以及下肢动脉疾病诊断方法的解释,并提供了选择性维生素D受体激活剂替代治疗继发性甲状旁腺功能亢进的优势的证据。强调CKD在1型糖尿病患者代谢、结构和血流动力学紊乱发展中的重要作用。
{"title":"Comprehensive assessment of cardiovascular complications in a patient with type 1 diabetes mellitus, chronic kidney disease and diabetic neuroosteoarthropathy","authors":"O. Bondarenko, Marianna V. Yaroslavceva, A. Y. Tokmakova, G. Galstyan, N. Tarbaeva","doi":"10.18786/2072-0505-2022-50-031","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-031","url":null,"abstract":"The paper presents a clinical case of the patient with long-term poor control of type 1 diabetes mellitus, chronic kidney disease (CKD) and diabetic neurоosteoarthropathy. The characteristics of interest in the clinical case are CKD complications associated with mineral and bone metabolism disorders. Clinical consequences of vascular calcification due to secondary hyperparathyroidism, autonomic and peripheral neuropathy have resulted in cardiovascular complications. We discuss the diagnostic challenges of vascular calcification, as well as the interpretation of diagnostic methods in lower limb arterial disease, and provide evidence for the advantages of alternative treatment of secondary hyperparathyroidism with a selective activator of vitamin D receptors. The important role of CKD in the development of metabolic, structural and hemodynamic disorders in patients with type 1 diabetes mellitus is emphasized.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81636503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Almanac of Clinical Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1